These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1121588)

  • 1. [Metabolic capacity of the liver for drugs in hepatobiliary patients].
    González Macias J; Herreros Fernández V; De Castro Del Pozo S
    Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disruption of the electrolyte and microelement composition of gastric juice and bile in patients with chronic diseases of the hepatobiliary system].
    Gubergrits AIa; Revutskiĭ BI; Shmakov VN
    Vrach Delo; 1989 May; (5):64-6. PubMed ID: 2773439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bile electrolytes in patients with chronic diseases of the liver and bile ducts].
    Revutskiĭ BI; Shmakov VN; Nechaev EN
    Vrach Delo; 1969 Oct; 10():118-20. PubMed ID: 5366772
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
    Gault MH; Stein J; Aronoff A
    Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of several mediators and enzymes in diseases of the hepatobiliary system].
    Barba EI; Vasiliuk VA; Kushnir VS
    Vrach Delo; 1976 Apr; (4):110-3. PubMed ID: 1007173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulation of ampicillin and sulfalene in liver disease patients].
    Iakovlev VP; Bobrov VI; Gal'perin EI; Volkova NV; Nazarova OI
    Antibiotiki; 1982 Aug; 27(8):619-23. PubMed ID: 7125622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of carbohydrate metabolism in children with chronic hepatobiliary system diseases].
    Smiian IS; Slobodian IM; Khodorchuk NIa; Babinets' TS
    Pediatr Akus Ginekol; 1975; (4):17-9. PubMed ID: 1064835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of serum isocitrate dehydrogenase in patients with hepatobiliary diseases].
    Cremer Nicolini G
    An Fac Med Lima; 1965 Jun; 48(2):297-317. PubMed ID: 5850391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B; Simon K; Gładysz A
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):268-70. PubMed ID: 8234040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of the determination of the gamma glutamine transferase enzyme in the diagnosis of liver and biliary tract diseases].
    Golubović G; Pandey L; Stajić M; Zvenigorodska O; Jovanović R
    Srp Arh Celok Lek; 1986; 114(11-12):1043-8. PubMed ID: 2884731
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Properdin system and liver diseases].
    Reissmann G
    Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of disease states on the pharmacokinetics of drugs. 2. Liver and biliary diseases].
    Pfeifer S
    Pharmazie; 1991 Sep; 46(9):623-32. PubMed ID: 1798726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical importance of studying the free biliary acids of the bile in certain diseases of the hepatobiliary system].
    Abramzon MA; Popova RA; Ripatti PO
    Vrach Delo; 1975 Mar; (3):72-4. PubMed ID: 1121842
    [No Abstract]   [Full Text] [Related]  

  • 16. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
    Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
    Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatobiliary changes in erythropoietic protoporphyria.
    Cripps DJ; Scheuer PJ
    Arch Pathol; 1965 Nov; 80(5):500-8. PubMed ID: 5844410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of protein metabolism in patients with surgical diseases of the liver and bile ducts].
    Borovkov SA; Tsubaka NIa
    Sov Med; 1968 Mar; 31(3):87-91. PubMed ID: 5674180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bioequivalence of phenylbutazone preparations following a single intramuscular administration].
    Weyhenmeyer R; Dingler E; Lohaus R; Mayer D; Teicher H; Wybitul K; Wangemann G; Steim H
    Arzneimittelforschung; 1984; 34(6):721-3. PubMed ID: 6541493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food and hepatobiliary disease on the excretion of josamycin.
    Bergan T; Tolås P; Oydvin B
    Pharmacology; 1972; 8(4):336-43. PubMed ID: 4572010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.